Replies to post #2572 on Skye Bioscience Inc (SKYE)

[TrueTrades]

we want to see an ind filed and fda clearance on a p2b efficacy trial of <6 months for this indication in line with 502(b)(2) submission
approval by 2019
$660m in first 3 years of approved usage
$8 by 2018 and $26 by 2020
nothing less will do